PpDC vaccine (Jonsson Comprehensive Cancer Center)

N/A

Report date: 2025/06/11 10:58:06

Base Information

Drug NamePpDC vaccine (Jonsson Comprehensive Cancer Center)

Drug Alias NamePeptide-pulsed dendritic cell vaccine (Jonsson Comprehensive Cancer Center)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Leukocyte cell therapyVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsGlioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsYes

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUclas Jonsson Comprehensive Cancer Center

China Registration ClassN/A

Develop Information

Active CompaniesUclas Jonsson Comprehensive Cancer Center

Inactive CompaniesN/A

Active IndicationsGlioma

Inactive IndicationsN/A

Other Information

ATC CodeN/A